Detalhe da pesquisa
1.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385243
2.
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK-cell counts in rituximab-chemotherapy responsive elderly DLBCL patients: A LYSA group study.
Br J Haematol
; 201(2): 256-266, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740991
3.
Mutational landscape of gray zone lymphoma.
Blood
; 137(13): 1765-1776, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961552
4.
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Blood
; 137(17): 2307-2320, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211799
5.
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 128(3): 519-528, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34605020
6.
Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma.
Haematologica
; 107(1): 221-230, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327711
7.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184451
8.
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
Eur J Nucl Med Mol Imaging
; 48(5): 1362-1370, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097974
9.
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
Future Oncol
; 17(11): 1295-1310, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528286
10.
Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
Br J Haematol
; 189(1): 84-96, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702836
11.
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
Blood
; 131(22): 2449-2453, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559480
12.
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.
Lancet Oncol
; 20(2): 202-215, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658935
13.
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Cancer
; 125(13): 2291-2299, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901086
14.
Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?
Blood
; 129(23): 3059-3070, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416502
15.
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
Health Qual Life Outcomes
; 17(1): 115, 2019 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266501
16.
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.
Am J Hematol
; 2018 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884994
17.
Bendamustine-based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers.
Am J Hematol
; 93(6): 729-735, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473209
18.
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet
; 388(10044): 565-75, 2016 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27313086
19.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Haematologica
; 107(7): 1681-1686, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965701
20.
Upfront eBEACOPP chemotherapy without consolidation radiotherapy in early-stage unfavourable Hodgkin lymphoma.
Lancet Oncol
; 22(2): 161-162, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539737